Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-06-19 Disposition | 2020-06-23 4:49 pm | N/A 2029-02-01 | PROGENICS PHARMACEUTICALS INC | PGNX | Das Asha Chief Medical Officer | 207,214 | $0 | 0 (Direct) | View |
| 2020-06-19 Disposition | 2020-06-23 4:49 pm | N/A 2028-02-29 | PROGENICS PHARMACEUTICALS INC | PGNX | Osorio Benedict COO | 294,166 | $0 | 0 (Direct) | View |
| 2020-06-19 Disposition | 2020-06-23 4:49 pm | N/A 2026-10-02 | PROGENICS PHARMACEUTICALS INC | PGNX | Tenbarge Bryce SVP, Commercial | 389,864 | $0 | 0 (Direct) | View |
| 2020-06-19 Disposition | 2020-06-23 4:48 pm | N/A 2020-06-30 | PROGENICS PHARMACEUTICALS INC | PGNX | Wong Vivien EVP, Development | 809,760 | $0 | 0 (Direct) | View |
| 2020-06-19 Disposition | 2020-06-23 4:48 pm | N/A 2029-12-13 | PROGENICS PHARMACEUTICALS INC | PGNX | Mims David W. Interim CEO and Interim CFO | 56,393 | $0 | 0 (Direct) | View |
| 2020-06-19 Disposition | 2020-06-23 4:48 pm | N/A 2029-12-13 | PROGENICS PHARMACEUTICALS INC | PGNX | Ber Gerard Director | 106,393 | $0 | 0 (Direct) | View |
| 2020-06-19 Disposition | 2020-06-23 4:47 pm | N/A 2026-06-07 | PROGENICS PHARMACEUTICALS INC | PGNX | Campbell Bradley L Director | 110,000 | $0 | 0 (Direct) | View |
| 2020-06-19 Disposition | 2020-06-23 4:47 pm | N/A 2029-12-13 | PROGENICS PHARMACEUTICALS INC | PGNX | Ende Eric J Director | 56,393 | $0 | 0 (Direct) | View |
| 2020-06-19 Disposition | 2020-06-23 4:47 pm | N/A 2024-01-28 | PROGENICS PHARMACEUTICALS INC | PGNX | Ferrante Karen Jean Director | 170,000 | $0 | 0 (Direct) | View |
| 2020-06-19 Disposition | 2020-06-23 4:46 pm | N/A 2029-12-13 | PROGENICS PHARMACEUTICALS INC | PGNX | MacDougall Ann L. Director | 76,065 | $0 | 0 (Direct) | View |
| 2020-06-19 Disposition | 2020-06-23 4:46 pm | N/A 2029-12-13 | PROGENICS PHARMACEUTICALS INC | PGNX | Maeusli Heinz Christoph Director | 56,393 | $0 | 0 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 4:15 pm | N/A 2030-03-02 | PROGENICS PHARMACEUTICALS INC | PGNX | Das Asha Chief Medical Officer | 82,214 | $0 | 82,214 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 4:15 pm | N/A 2030-03-02 | PROGENICS PHARMACEUTICALS INC | PGNX | Osorio Benedict COO | 82,214 | $0 | 82,214 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 4:15 pm | N/A 2030-03-02 | PROGENICS PHARMACEUTICALS INC | PGNX | Wong Vivien EVP, Development | 82,214 | $0 | 82,214 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 4:15 pm | N/A 2030-03-02 | PROGENICS PHARMACEUTICALS INC | PGNX | Tenbarge Bryce SVP, Commercial | 82,214 | $0 | 82,214 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 4:15 pm | N/A 2030-03-02 | PROGENICS PHARMACEUTICALS INC | PGNX | Fabbio Patrick CFO | 82,214 | $0 | 82,214 (Direct) | View |